ENDRA Life Sciences Inc. (NDRA) stock
NDRANasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$4.04+0.12 (+2.93%)
Close on Nov 18, 2026Market cap $6.05MP/E –Yield –
ENDRA Life Sciences operating margin
Operating margin is operating income as a percentage of revenue.
ENDRA Life Sciences's operating margin for the twelve months ending Dec 31, 2018 was -146080.5%. For fiscal 2018 it was -146080.5%, against -1315.6% the year before.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | -146080.5% | −144764.8 |
| FY2017 | Dec 31, 2017 | -1315.6% | −968.1 |
| FY2016 | Dec 31, 2016 | -347.5% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2018 | Mar 31, 2018 | -45960.8% | −45898.9 |
| Q4 FY2017 | Dec 31, 2017 | -33526.6% | – |
| Q3 FY2017 | Sep 30, 2017 | -317.4% | – |
| Q2 FY2017 | Jun 30, 2017 | -1829.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -61.8% | – |
See a number that looks wrong?